Wetzel Investment Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Wetzel Investment Advisors’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,000	Closed	–	–	1103
2023 Q4	$0	Buy	+2,000	New	–	﹤0.01%	1064

Wetzel Investment Advisors's BLCM Position: Q1 2024 in Review

Wetzel Investment Advisors sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2024, closing a stake of 2,000 shares.

Wetzel Investment Advisors first reported a position in BLCM in Q4 2023 and held it in 1 quarter. The position peaked at $0 in Q4 2023. 0 funds tracked by Wall St. Rank hold BLCM as of Q1 2024.

Wetzel Investment Advisors reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
Wetzel Investment Advisors sold 2,000 Bellicum Pharmaceuticals, Inc. shares in Q1 2024.
Wetzel Investment Advisors first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2023 and held it in 1 quarter.
Wetzel Investment Advisors's Bellicum Pharmaceuticals, Inc. position peaked at $0 in Q4 2023.
0 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2024.

Based on Wetzel Investment Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.